Targeting G3BP1-Mediated Stress Granules to Suppress SARS-CoV-2 Replication
ACS Infectious Diseases · 09.10.2026 · 12 (10) · 3322-3334
DOI: 10.1021/acsinfecdis.5c01026 ↗Kurz gefasst
Fachartikel in der Zeitschrift ACS Infectious Diseases, online erschienen am 10.04.2026. Verfasst von Rukayat Aromokeye und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology and Toxicology, R. Ken Coit College of Pharmacy, University of Arizona, Tucson, Arizona85721, United States. Hauptthemen laut MEDLINE: RNA Recognition Motif Proteins, Poly-ADP-Ribose Binding Proteins, RNA Helicases, Stress Granules. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 51 Literaturangaben. Gefördert von: BLRD VA, NINDS NIH HHS, National Institute of Allergy and Infectious Diseases.
Abstract (Originalsprache)
Stress granules (SGs) are cytoplasmic, membraneless assemblies of proteins and RNAs that transiently form in response to cellular stress. Dysregulation of SGs has been associated with cancer, neurodegeneration, and viral infection. GTPase-activating protein SH3 domain-binding protein 1 (G3BP1) is a central SG component that regulates granule assembly and dynamics through protein-RNA and protein–protein interactions (PPIs). During viral infection, SGs can be hijacked to enhance viral replication and suppress host defense. In this study, we show that severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) nucleocapsid protein (N) binds G3BP1 and localizes to G3BP1-positive SGs in infected cells. We hypothesize that small-molecule ligands targeting G3BP1 can disrupt the G3BP1-N interaction and reduce viral replication. To test this, we developed a robust, miniaturized, 384-well time-resolved fluorescence resonance energy transfer (TR-FRET) assay for high-throughput screening (HTS). Screening a library of 2560 FDA-approved drugs yielded 17 hits. Subsequent counterscreening, validation, and biophysical binding studies identified 7 PPI inhibitors with IC50 values ranging from 0.8 to 31 μM. In cell-based assays, two compounds─dexlansoprazole and citalopram─disrupted the G3BP1-N interaction with minimal cytotoxicity. Both compounds showed antiviral activity in human lung epithelial cells infected with either the WA strain or an Omicron (BA.1) strain of SARS-CoV-2. This work establishes a strategy to modulate SGs by targeting a host–virus PPI, highlighting G3BP1 as a potential therapeutic node for antiviral intervention.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmacology and Toxicology, R. Ken Coit College of Pharmacy, University of Arizona, Tucson, Arizona85721, United States.
- Department of Chemistry and Biochemistry, University of Arizona, Tucson, Arizona85721, United States.
- The BIO5 Institute, University of Arizona, Tucson, Arizona85721, United States.
- Department of Molecular & Cellular Biology, College of Science, University of Arizona, Tucson, Arizona85721, United States.
- Research Service, Department of Veteran Affairs Southern Arizona Health Care, Tucson, Arizona85713, United States.
ORCID-Profile: Haining Zhu
Förderung
- BLRD VA
- NINDS NIH HHS
- National Institute of Allergy and Infectious Diseases
- U.S. Department of Veterans Affairs
- University of Arizona
- National Institute of Neurological Disorders and Stroke
Zitieren
APA
Aromokeye, R., Kuang, L., Ackerman-Berrier, M., Cardoza, S., Holberg, C., Carver, M., Ma, C., Tharappel, A. M., Li, H., Wang, L., Thatcher, G. R. J., & Zhu, H. (2026). Targeting G3BP1-Mediated Stress Granules to Suppress SARS-CoV-2 Replication. ACS Infectious Diseases, 12(10), 3322-3334. https://doi.org/10.1021/acsinfecdis.5c01026
Vancouver
Aromokeye R, Kuang L, Ackerman-Berrier M, Cardoza S, Holberg C, Carver M, et al. Targeting G3BP1-Mediated Stress Granules to Suppress SARS-CoV-2 Replication. ACS Infectious Diseases. 2026;12(10):3322-3334. doi:10.1021/acsinfecdis.5c01026
BibTeX
@article{Aromokeye2026,
author = {Aromokeye, Rukayat and Kuang, Lisha and Ackerman-Berrier, Martha and Cardoza, Savio and Holberg, Cameron and Carver, Megan and Ma, Chunlong and Tharappel, Anil Mathew and Li, Hongmin and Wang, Lei and Thatcher, Gregory R J and Zhu, Haining},
title = {Targeting G3BP1-Mediated Stress Granules to Suppress SARS-CoV-2 Replication},
journal = {ACS Infectious Diseases},
year = {2026},
volume = {12},
number = {10},
pages = {3322--3334},
doi = {10.1021/acsinfecdis.5c01026}
}
EUVIMED